Literature DB >> 8139000

Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses.

M Grez1, U Dietrich, P Balfe, H von Briesen, J K Maniar, G Mahambre, E L Delwart, J I Mullins, H Rübsamen-Waigmann.   

Abstract

DNA sequences encoding the surface envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) were amplified by PCR from uncultured peripheral blood mononuclear cells obtained from patients with serologically defined HIV-1/HIV-2 mixed infections from Bombay, India. HIV-1-specific PCR products were obtained in seven of seven randomly chosen doubly reactive cases, while HIV-2-specific sequences were detected in five of seven cases (71%). DNA sequence analysis showed that the HIV-1 gp120 coding sequences were closely related to each other (nucleotide sequence divergence of between 3.1 and 6.8%). Phylogenetic tree analysis placed the Indian strains within the C subtype of HIV-1, being most similar to sequences previously found in East and South Africa. The HIV-2 sequences were also closely related to each other, with an overall sequence divergence of between 5.6 and 10.5%. The low level of nucleotide divergence among Indian HIV-1 and HIV-2 sequences suggests a fairly recent introduction of each virus into this population from a single point of entry in each case. The HIV-2 sequences reported here represent the first analysis of Asian HIV-2 strains and confirm the serological pattern previously detected in India. These data show that a substantial spread of HIV-2, together with HIV-1, has appeared outside Africa in a population hitherto unexposed to HIV. These findings imply that further spread of HIV-2 worldwide is to be expected and have important implications for future vaccine and therapy development.

Entities:  

Keywords:  Asia; Developing Countries; Diseases; Examinations And Diagnoses; Genetic Technics; Hiv Infections; India; Laboratory Examinations And Diagnoses; Laboratory Procedures; Southern Asia; Viral Diseases

Mesh:

Substances:

Year:  1994        PMID: 8139000      PMCID: PMC236691     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients.

Authors:  M Alizon; S Wain-Hobson; L Montagnier; P Sonigo
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

2.  Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions.

Authors:  M Nei; T Gojobori
Journal:  Mol Biol Evol       Date:  1986-09       Impact factor: 16.240

3.  HIV-I and HIV-II double infection in Central African Republic.

Authors:  F Rey; D Salaun; J L Lesbordes; S Gadelle; F Ollivier-Henry; F Barré-Sinoussi; J C Chermann; A J Georges
Journal:  Lancet       Date:  1986-12-13       Impact factor: 79.321

4.  Kaposi's sarcoma in an Indian woman infected with HIV-1 and HIV-2.

Authors:  H Rübsamen-Waigmann; M Grez; H von Briesen; U Dietrich; H J Shroff; E E Kaaya; P Biberfeld
Journal:  AIDS Res Hum Retroviruses       Date:  1993-06       Impact factor: 2.205

5.  A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences.

Authors:  M Kimura
Journal:  J Mol Evol       Date:  1980-12       Impact factor: 2.395

6.  Genome organization and transactivation of the human immunodeficiency virus type 2.

Authors:  M Guyader; M Emerman; P Sonigo; F Clavel; L Montagnier; M Alizon
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

7.  Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.

Authors:  E L Delwart; E G Shpaer; J Louwagie; F E McCutchan; M Grez; H Rübsamen-Waigmann; J I Mullins
Journal:  Science       Date:  1993-11-19       Impact factor: 47.728

8.  Evolution of human immunodeficiency virus type 1 nucleotide sequence diversity among close contacts.

Authors:  H Burger; B Weiser; K Flaherty; J Gulla; P N Nguyen; R A Gibbs
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

9.  Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro.

Authors:  K Kusumi; B Conway; S Cunningham; A Berson; C Evans; A K Iversen; D Colvin; M V Gallo; S Coutre; E G Shpaer
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic.

Authors:  K M De Cock; G Adjorlolo; E Ekpini; T Sibailly; J Kouadio; M Maran; K Brattegaard; K M Vetter; R Doorly; H D Gayle
Journal:  JAMA       Date:  1993-11-03       Impact factor: 56.272

View more
  25 in total

1.  Analysis of HIV type 1 BF recombinant sequences from South America dates the origin of CRF12_BF to a recombination event in the 1970s.

Authors:  Dario A Dilernia; Leandro R Jones; Maria A Pando; Roberto D Rabinovich; Gabriel D Damilano; Gabriela Turk; Andrea E Rubio; Sandra Pampuro; Manuel Gomez-Carrillo; Horacio Salomón
Journal:  AIDS Res Hum Retroviruses       Date:  2010-12-03       Impact factor: 2.205

2.  Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis.

Authors:  L M Janini; D Pieniazek; J M Peralta; M Schechter; A Tanuri; A C Vicente; N dela Torre; N J Pieniazek; C C Luo; M L Kalish; G Schochetman; M A Rayfield
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

3.  Human immunodeficiency virus type 1 intersubtype (B/E) recombination in a superinfected chimpanzee.

Authors:  P N Fultz; L Yue; Q Wei; M Girard
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein.

Authors:  A McKnight; C Shotton; J Cordell; I Jones; G Simmons; P R Clapham
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

5.  Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

Authors:  F Gao; S G Morrison; D L Robertson; C L Thornton; S Craig; G Karlsson; J Sodroski; M Morgado; B Galvao-Castro; H von Briesen; S Beddows; J Weber; P M Sharp; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Phylogenetic characterization of six full-length HIV-1 subtype C molecular clones from three patients: identification of rare subtype C strains containing two NF-κB motifs in the long terminal repeat.

Authors:  Luke Elizabeth Hanna; Ujjwal Neogi; Udaykumar Ranga; Soumya Swaminathan; Vinayaka R Prasad
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-07       Impact factor: 2.205

7.  Early evolution of the human immunodeficiency virus type 1 subtype C epidemic in rural Malawi.

Authors:  Grace P McCormack; Judith R Glynn; Amelia C Crampin; Felix Sibande; Dominic Mulawa; Lyn Bliss; Philip Broadbent; Katia Abarca; Jorg M Pönnighaus; Paul E M Fine; Jonathan P Clewley
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  HIV - 1 SUBTYPES, ITS IMPLICATIONS AND VIRAL DYNAMICS.

Authors:  A K Sahni; A Nagendra; P K Menon
Journal:  Med J Armed Forces India       Date:  2011-07-21

9.  Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement.

Authors:  L G Kostrikis; Y Cao; H Ngai; J P Moore; D D Ho
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology.

Authors:  F Gao; L Yue; D L Robertson; S C Hill; H Hui; R J Biggar; A E Neequaye; T M Whelan; D D Ho; G M Shaw
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.